Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Leveraging FHF modulation to inhibit arrhythmogenic late sodium current

Fibroblast growth factor homologous factors (FHFs) are an auxiliary subunit of the cardiac voltage-gated sodium channel. We found that FHFs can inhibit the arrhythmogenic late sodium current (INa,L) in an isoform-specific manner, and engineered an FHF-based cell-penetrating peptide that acts as an inhibitor of INa,L and opens avenues for developing future therapeutics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: FHFs as potent INa,L inhibitors.

References

  1. Remme, C. A., Wilde, A. A. M. & Bezzina, C. R. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc. Med. 18, 78–87 (2008). A review article that summaries variable clinical manifestations of cardiac NaV1.5 channelopathies.

    Article  CAS  Google Scholar 

  2. Horvath, B. & Bers, D. The late sodium current in heart failure: pathophysiology and clinical relevance. ESC Heart Fail. 1, 26–40 (2014). A review article that presents recent advances in understanding of the role of INa,L in cardiac pathophysiology.

    Article  Google Scholar 

  3. Abrams, J. M. et al. Fibroblast growth factor homologous factors tune arrhythmogenic late NaV1.5 current in calmodulin-binding-deficient channels. JCI Insight 5, e141736 (2020). A paper that shows that FHF inhibits INa,L.

    Article  Google Scholar 

  4. Goldfarb, M. Voltage gated sodium channel associated proteins and alternative mechanisms of inactivation and block. Cell. Mol. Life Sci. 69, 1067–1076 (2012). A review article that highlights the role of FHF in tuning NaV1.5 inactivation.

    Article  CAS  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Chakouri, N. et al. Fibroblast growth factor homologous factors serve as a molecular rheostat in tuning arrhythmogenic cardiac late sodium current. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-022-00060-6 (2022).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leveraging FHF modulation to inhibit arrhythmogenic late sodium current. Nat Cardiovasc Res 1, 548–549 (2022). https://doi.org/10.1038/s44161-022-00077-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-022-00077-x

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing